World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
24884
World Ranking
12826
National Ranking
6557

Overview

Paul J. Thuluvath is affiliated with Mercy Medical Center in the United States and specializes in Medicine with a focus on Hepatology. Their research portfolio encompasses over 278 publications primarily within the disciplines of liver disease, transplantation, and related clinical fields.

The scientist's recent published papers include:

  • Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases, 2021, Journal of Hepatology
  • Gastrointestinal and Liver Manifestations of COVID-19, 2020, Journal of Clinical and Experimental Hepatology
  • Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis, 2020, Hepatology International
  • Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis, 2020, Gastroenterology
  • Hyponatremia in Cirrhosis: An Update, 2020, The American Journal of Gastroenterology

Their frequent co-authors are:

  • Jasmohan S. Bajaj
  • K. Rajender Reddy
  • Patrick S. Kamath
  • Leroy R. Thacker
  • Hugo E. Vargas

Paul J. Thuluvath's work is often published in several key academic venues, including:

  • Journal of Hepatology
  • Gastroenterology
  • The American Journal of Gastroenterology
  • Digestive Diseases and Sciences
  • Journal of Clinical and Experimental Hepatology

Major fields and subfields of study associated with their work are:

  • Medicine

  • Hepatology
  • Epidemiology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Main research topics covered by Paul J. Thuluvath include:

  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Hepatitis C virus research
  • Liver Diseases and Immunity
  • Electrolyte and hormonal disorders
  • COVID-19 Clinical Research Studies

Additionally, the scientist has contributed to book publications, including a title published by Johns Hopkins University Press:

  • Your Complete Guide to Liver Health, 2022

Best Publications

  • Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

    Mark S. Sulkowski;David F. Gardiner;Maribel Rodriguez-Torres;K. Rajender Reddy

  • All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study

    David R. Nelson;James N. Cooper;Jacob P. Lalezari;Eric Lawitz

  • Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study

    Asma Poonawala;Satheesh P. Nair;Paul J. Thuluvath

  • Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.

    Satheesh Nair;Sumita Verma;Paul J. Thuluvath

  • SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

    Andrew X. Zhu;Olivier Rosmorduc;T. R Jeffry Evans;Paul J. Ross

  • Liver Transplantation in the United States, 1999–2008

    P. J. Thuluvath;M. K. Guidinger;J. J. Fung;L. B. Johnson

  • Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.

    Satheesh Nair;Sumita Verma;Paul J. Thuluvath;Paul J. Thuluvath

  • Acute hepatitis C

    Anurag Maheshwari;Stuart Ray;Paul J Thuluvath

  • A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo-controlled trial

    Florence Wong;Andres T. Blei;Laurence M. Blendis;Paul J. Thuluvath

  • MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3

    Florin M. Selaru;Alexandru V. Olaru;Takatsugu Kan;Stefan David

  • Independent risk factors and natural history of renal dysfunction in liver transplant recipients

    Attaphol Pawarode;Derek M. Fine;Paul J. Thuluvath

  • The Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma in the United States Between 1988 and 2001: 5-Year Survival Has Improved Significantly With Time

    Hwan Y. Yoo;Cary H. Patt;Jean Francois Geschwind;Paul J. Thuluvath

  • Biliary complications after liver transplantation: the role of endoscopy.

    P. J. Thuluvath;P. R. Pfau;M. B. Kimmey;G. G. Ginsberg

  • Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

    Naga Chalasani;Manal F. Abdelmalek;Guadalupe Garcia-Tsao;Raj Vuppalanchi

  • Endoscopic suturing closure of large mucosal defects after endoscopic submucosal dissection is technically feasible, fast, and eliminates the need for hospitalization (with videos)

    Sergey V. Kantsevoy;Marianne Bitner;Aleksandr A. Mitrakov;Paul J. Thuluvath

  • An endoscopic approach to biliary complications following orthotopic liver transplantation.

    Paul J. Thuluvath;Tamer Atassi;John Lee

  • Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

    Gregory T. Everson;Karen D. Sims;Maribel Rodriguez-Torres;Christophe Hézode

  • Portal Hypertensive gastropathy.

    Paul J Thuluvath;Hwan Y Yoo

  • Human bile contains MicroRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis

    Ling Li;David Masica;Masaharu Ishida;Ciprian Tomuleasa

  • Spontaneous bacterial peritonitis - In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998

    Paul J Thuluvath;Sydney Morss;Richard Thompson

Frequent Co-Authors

Guadalupe Garcia-Tsao
Guadalupe Garcia-Tsao Yale University
Florence Wong
Florence Wong University of Toronto
Jasmohan S. Bajaj
Jasmohan S. Bajaj Virginia Commonwealth University
K. Rajender Reddy
K. Rajender Reddy University of Pennsylvania
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Dorry L. Segev
Dorry L. Segev Johns Hopkins University
Anirban Maitra
Anirban Maitra The University of Texas MD Anderson Cancer Center
Stanislas Pol
Stanislas Pol Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens several related education pathways beyond a traditional MD program. One rapidly growing area is healthcare management. For those interested in leadership or administrative roles, earning a health administration degree online can provide the necessary skills to oversee hospitals, clinics, and healthcare systems.

Professionals already holding a bachelor’s degree can advance with a master's in healthcare administration online, which offers training in policy, finance, and organizational leadership. This degree is ideal for those aiming for executive positions in the healthcare sector.

For nurses seeking top-level clinical roles, enrolling in the best online dnp programs can lead to advanced practice and leadership opportunities. A Doctor of Nursing Practice (DNP) focuses on transforming healthcare at both the patient and system levels.

Additionally, those interested in pharmaceutical careers can expand their expertise through online pharmacy schools. These programs prepare graduates for flexible roles in hospitals, clinics, research, and retail pharmacy.

Best Scientists Citing Paul J. Thuluvath

Trending Scientists

Recently Published Articles